جست‌وجوی استاد و پژوهشگر

• Physiology
• Cancer biology
• pH regulation
• +۵ مورد دیگر

Pawel Swietach is Professor of Physiology at the University of Oxford, Head of the Proton Transport Group (DPAG), and Handa Tutorial Fellow at Corpus Christi College. His work bridges cardiac physiology , cancer pH biology , and blood oxygen transport , with a focus on acid-base regulation and its therapeutic implications. PhD in Physiology (Oxford, 2004) First Class BA in Physiological Sciences (Oxford, 2001) His research uncovers how pH gradients govern cell function in heart and cancer, including: Proton-calcium crosstalk in cardiomyocytes Metabolic adaptation to acidosis in tumors Biochemical control of oxygen release in stored blood His 15 most recent publications (2020-2025) span Nature Reviews Cancer , Nature Cardiovascular Research , and Cell Reports , focusing on acid-driven oncogenesis, histone modifications from propionate metabolism, and novel methods for imaging oxygen transport. Key findings include tumor-stroma acid exchange via gap junctions and nuclear pH's role in cardiac gene expression. Honors include: ERC Consolidator Grant (2017) Royal Society University Research Fellowship (2008-2016) CRUK-U.S. Fulbright Scholar (2018) Academia Europaea membership (2024) He leads cross-disciplinary projects funded by British Heart Foundation, ERC, MRC, and industry partners, translating pH biology into clinical tools like FlowScore for blood storage quality assessment.

Ann Maineمشاهده پروفایل

استادیار

• Molecular Biology
• Developmental Biology
• Biochemistry
• +۳ مورد دیگر

Ann Maine is an Assistant Professor of Biology at Lake Forest College since 1994. She holds a BA in Biology from Williams College, an MA and PhD in Biochemistry from the University of Rochester. Her research focuses on gene expression regulation during developmental stages and cellular changes in carcinogenesis. She teaches courses emphasizing science education for non-science majors. Education : BA Biology (Williams College), MA/PhD Biochemistry (University of Rochester) Research Interests : Developmental gene regulation, aldolase enzyme systems, molecular mechanisms in carcinogenesis Her publications analyze gene expression patterns in mice, particularly in aldolase genes and liver cancer models. No awards mentioned. No student advising details available. Active in undergraduate teaching and curriculum design.

• Artificial Intelligence in Radiology
• Machine Learning
• Health Informatics
• +۲ مورد دیگر

Dr. Axel W. E. Wismüller is a Professor of Radiology and Biomedical Engineering at the University of Rochester Medical Center . As Director of the AI Radiology Laboratory , he uniquely combines clinical practice in cardiothoracic/body imaging with pioneering research in Artificial Intelligence (AI) for medical imaging . Holding MD, MSc (Physics), and PhD (Electrical Engineering) degrees from German institutions, he maintains dual US and German medical licenses and board certifications. Ludwig-Maximilians-Universitaet München (1990-1996) Technical University of Munich (MD 1992, PhD 2006) Ludwig Maximilians University Munich (Residency 1997-2005) His research focuses on machine learning and network connectivity analysis in neuroimaging, particularly for HIV-associated neurocognitive disorders and multiple sclerosis . He invented the XOM algorithm (patented in US/EU) and developed AI systems for chest radiograph analysis , breast cancer imaging , and osteoporosis diagnostics . His work on large-scale Granger causality has transformed brain network analysis methodology. Scientific awards include SPIE Senior Membership (2016), NIH/NIDA R01 funding (2012-2015), and NYSTAR public-private partnerships . Supervising over 30 PhD/MSc students across engineering, computer science, and medicine , he bridges clinical and computational disciplines through active roles in ACR, RSNA, and SPIE .

• Functional Magnetic Resonance Imaging (fMRI)
• Metabolic Brain Diseases
• Neuroimaging Techniques
• +۵ مورد دیگر

Gang Zheng is a Research Fellow at Monash Biomedical Imaging, Monash University. He holds a PhD in Biomedical Engineering (2007) from Nanjing University of Aeronautics and Astronautics and a bachelor's in Science (2002). Previously, he served as an associate professor (2014) and lecturer (2008) at his alma mater, conducting clinical radiology research at Jinling Hospital. His current research focuses on developing noninvasive fMRI techniques for metabolic brain diseases like hepatic encephalopathy and Alzheimer’s risk detection, with expertise in arterial spin labeling MRI and brain connectome analysis. Education: PhD in Biomedical Engineering, Nanjing University of Aeronautics and Astronautics (2007) Bachelor of Science, Nanjing University of Aeronautics and Astronautics (2002) Research Highlights: Advances in fMRI techniques for metabolic disorders Cardiac fibrosis imaging in preclinical models Neuroinflammation modulation post-TBI STING pathway inhibition therapies Awards & Recognition: None explicitly listed Collaborations: University of Pennsylvania (functional neuroimaging), Cancers research networks

Stefaan Verbruggenمشاهده پروفایل

مدرس

• Bone biomechanics
• Cancer mechanobiology
• Developmental biomechanics
• +۴ مورد دیگر

Dr. Stefaan Verbruggen is a Lecturer in Medical Technology at Queen Mary University of London (QMUL), affiliated with the School of Engineering and Materials Science and the Centre for Bioengineering. He holds a BEng and PhD from the National University of Ireland Galway and is a Fellow of the Higher Education Academy. His research focuses on bone mechanobiology, cancer metastasis, and organ-on-a-chip technologies. As a Visiting Academic at the INSIGNEO Institute for in silico Medicine, he develops computational models of metastatic bone lesions. Prior roles include postdoctoral research at Imperial College London and a Marie Sklodowska-Curie Research Fellowship at QMUL. He collaborates extensively with institutions like Columbia University. Research interests include bone cell mechanobiology, developmental biomechanics, and predictive in vitro models for cancer. Key projects involve modeling fetal movement effects on joint development and elucidating how mechanical forces influence cancer cell behavior. He leads grants totaling over £1.8M, including initiatives to reduce animal testing via organ-on-a-chip platforms. Awards include the Marie Curie Fellowship and the European Society of Biomechanics’ S.M. Perren Award (2018). Teaching roles include organizing modules in medical imaging and biomedical engineering. His work spans interdisciplinary collaborations in oncology, biomechanics, and tissue engineering, with a focus on translating computational insights into clinical applications.

Kathleen O'Connorمشاهده پروفایل

استاد

• Cancer Biology
• Integrin Signaling
• Cell Invasion and Metastasis
• +۷ مورد دیگر

Kathleen O'Connor is a Professor in the Department of Molecular and Cellular Biochemistry at the University of Kentucky, where she also serves as the Associate Director of Cancer Education in the Markey Cancer Center. She is a member of the Markey Cancer Center’s Cancer Research Priority Initiative and the Molecular and Cellular Oncology Research Program, as well as the UNITE Research Priority Area. Her interdisciplinary roles reflect her leadership in cancer research and education. Doctor of Philosophy, Case Western Reserve University, 1996 Bachelor of Science, James Madison University, 1988 Dr. O'Connor's research focuses on the molecular mechanisms of cancer progression, particularly how integrin receptors—especially α6β4—mediate signaling that drives carcinoma cell invasion. Her lab investigates the interplay between integrin signaling and cyclic AMP metabolism, Rho GTPase regulation, and the expression of pro-invasive genes such as autotaxin, S100A4, and EGFR ligands. This work has significant implications for understanding the aggressive behavior of cancers in the breast, colon, and pancreas. Her recent publications (2022–2025) highlight sustained contributions to cancer biology, with studies on integrin-mediated chemosensitization, cytoskeletal regulation of invasion, and social determinants of breast cancer outcomes. These works span disciplines including molecular oncology, cell signaling, and health disparities, reflecting a broad and impactful research portfolio. Scientific awards include: Distinguished Faculty Teaching Award, Nominee (2006) Wethington Excellence in Research Award (2013, 2014, 2017) Women in Medicine and Science Mentorship, Finalist (2018) Dr. O'Connor is actively involved in mentoring and training the next generation of scientists. She leads several funded initiatives, including the Markey STRONG Post-baccalaureate Program and a Diversity in Cancer Research Supplement from the American Cancer Society, aimed at increasing representation of underrepresented minorities in biomedical research. She is the Principal Investigator (PI) on multiple active grants, including projects focused on triple-negative breast cancer and chemotherapy optimization, funded by the American Cancer Society and the National Cancer Institute. Her work bridges basic science and translational applications, with collaborations across institutions and disciplines. She is embedded in a vibrant research ecosystem at the Markey Cancer Center, where she contributes to education, mentorship, and collaborative research networks aimed at combating cancer through innovative science and inclusive training programs.

Pierre Lafayeمشاهده پروفایل

پژوهشگر

• Antibody Engineering
• Nanobodies (VHH)
• Immunotherapy
• +۱۳ مورد دیگر

Pierre Lafaye is the Head of the Antibody Engineering Platform at the Institut Pasteur, a leading institution in biological and medical research. His work is situated within the Technology Department, where he leads a core facility focused on the development and application of VHH (nanobody) technologies. The platform supports a wide range of academic and translational research projects, leveraging the unique properties of nanobodies such as small size, high stability, tissue penetration, and blood-brain barrier crossing ability. Research Interests: Dr. Lafaye’s research spans multiple domains, including cancer immunotherapy (e.g., targeting ILT4 as an immune checkpoint), neurodegenerative diseases (e.g., imaging Alzheimer’s plaques and tangles), infectious diseases (e.g., SARS-CoV-2 diagnostics and therapeutics), and antimicrobial resistance (e.g., targeting β-lactamases). His expertise lies in phage display, protein engineering, and in vivo molecular imaging. He has pioneered the use of dimeric VHHs for sensitive immunoassays and targeted diagnostics. Recent Publication Trends: His recent publications (2021–2024) reflect a strong emphasis on structural biology (using cryo-EM), viral entry mechanisms (especially coronaviruses), and the therapeutic and diagnostic application of nanobodies. Collaborative, high-impact studies in journals like Nature , Cell , and Nature Communications highlight his role in cutting-edge interdisciplinary research. Scientific Awards: While no specific awards are listed in the provided text, his leadership in IBiSA-certified core facilities and participation in major networks like EuroMabNet, Core For Life (CFL), and CTLS reflect recognition of his technical and scientific contributions. Advising and Grants: Dr. Lafaye has supervised multiple PhD students and postdoctoral researchers, indicating an active mentoring role. He leads several funded projects, including the ongoing CORONABODIES and Advances in Cancer Immunotherapy projects, as well as completed initiatives like ChagasDiag and VenoMATIcs. These projects involve collaborations across international Pasteur Institutes and academic partners. Labs and Teams: As head of the Antibody Engineering Platform, he oversees a multidisciplinary team comprising research engineers, technicians, postdocs, and PhD students. The facility is part of broader transversal initiatives at the Institut Pasteur, including those in brain connectivity, cancer, and emerging infectious diseases.

Lucie Pedutoمشاهده پروفایل

پژوهشگر

• Cancer biology
• Immunology
• Stromal microenvironment
• +۱۱ مورد دیگر

Lucie Peduto is a Principal Investigator and Structure Manager at the Institut Pasteur in Paris, where she leads a research team investigating the role of stromal and perivascular cells in immunity, inflammation, regeneration, and cancer. Her work focuses on understanding how the stromal microenvironment regulates intestinal homeostasis, tumor progression, and immune responses. Her research interests include: Cancer biology and tumor microenvironment Intestinal immunity and barrier function Mesenchymal and perivascular stromal cells Inflammation and fibrosis Regenerative mechanisms and tissue repair Immune cell-stromal cell crosstalk The recent publications highlight a strong focus on stromal regulation in immunity and cancer, with particular emphasis on PDGFRα+ mesenchymal cells, intestinal barrier integrity, and macrophage interactions. Her work integrates genetic models, organoid systems, and immunological assays to dissect molecular and cellular mechanisms in vivo. Scientific awards and recognitions: ERC Proof of Concept Grant 2023 Dr. Peduto supervises several postdoctoral fellows and PhD students, indicating an active mentoring and training role. She leads multiple funded projects, including ERC-CoG-PERIF on perivascular cells in inflammation and regeneration. Her research is supported by major initiatives at the Institut Pasteur, including the Cancer Initiative and stem cell programs. She collaborates with other leading immunologists and cell biologists at the institute and internationally.

Weihua Zhouمشاهده پروفایل

دانشیار

• Health Informatics
• Medical Image Analysis
• Machine Learning
• +۳ مورد دیگر

Weihua Zhou is a Tenured Associate Professor at Michigan Technological University in the College of Computing, with affiliations in Applied Computing, Biomedical Engineering, Computer Science, Electrical and Computer Engineering, and Mathematical Sciences. He holds a PhD from Southern Illinois University Carbondale, an MS and B.Eng. from Wuhan University, and completed postdoctoral research at Emory University. Academic Positions : Tenured Associate Professor (2025–present), Tenure-Track Assistant Professor (2019–2025) at Michigan Tech; Nina Bell Suggs Endowed Professorship (2015–2019) at the University of Southern Mississippi. Research Interests : Focuses on medical imaging and health informatics , particularly machine learning applications in cardiovascular diagnosis , osteoporosis risk stratification , and senile dementia early detection . Additional work includes radiomics for COVID-19 severity assessment , federated learning in medical segmentation , and deep learning for proximal femur strength prediction . Scientific Awards : USM Nina Bell Suggs Endowed Professorship, USM College of Arts and Sciences Scholarly Research Award, American Heart Association Research Leaders Academy (2017, 2018), USM Butch Oustalet Distinguished Professorship Research Award. Lab & Tools : Leads the Medical Imaging & Informatics Lab (MIILab-MTU) and contributes to the NSF/MRI GPU Cluster. Open-sourced tools include KD4COVID19 for radiomics analysis and ECGTools for ECG classification.

• Computer Vision
• Medical Image Analysis
• Pattern Recognition
• +۵ مورد دیگر

Jaime S. Cardoso is a prominent researcher at the University of Porto and Institute for Systems and Computer Engineering, Technology and Science (INESC TEC) in Portugal. His extensive publication record spanning two decades demonstrates his leadership in computer vision, medical image analysis, and pattern recognition. His research primarily focuses on applying artificial intelligence to healthcare challenges, particularly in medical imaging and diagnostics. Cardoso's research interests center on explainable AI for medical applications, biometrics, and computer vision. His work bridges the gap between theoretical machine learning and practical medical solutions, with significant contributions to breast cancer diagnosis, medical image segmentation, and biometric security systems. He has developed innovative approaches to medical image analysis, including virtual staining techniques and privacy-preserving explanation methods for medical AI systems. His recent publications (2023-2025) reveal a strong emphasis on explainable AI in medical contexts, with multiple papers addressing how to make deep learning models more transparent and trustworthy for healthcare applications. He has also made significant contributions to face recognition technology, video anomaly detection, and specialized medical imaging techniques for breast cancer and neonatal EEG analysis. Among his scientific contributions are numerous collaborations with researchers across Portugal and internationally. His work has appeared in top-tier journals including IEEE Access, Medical Image Analysis, and Neurocomputing, reflecting the high impact of his research. Cardoso has supervised numerous students who have become established researchers in their own right, including Ricardo P. M. Cruz, Kelwin Fernandes, and Ana Filipa Sequeira. His research group appears to focus on the intersection of deep learning, medical imaging, and biometrics, with strong connections to clinical applications.

Ellen Potoczkyمشاهده پروفایل

پژوهشگر ارشد

• Cell Biology
• Molecular Biology
• Epithelial Biology
• +۲ مورد دیگر

Dr. Ellen Potoczky is a Postdoctoral Research Fellow at the Institute for Molecular Bioscience, University of Queensland, specializing in cellular and molecular mechanisms of epithelial biology. Her educational background includes: Bachelor of Biomedical Science from the University of Adelaide Bachelor (Honours) of Biomedical Science from the University of South Australia Doctoral (Research) in Developmental Biology from the University of South Australia Her research focuses on Cell Biology, Molecular Biology, and Epithelial Biology, investigating how adherens junctions mediate mechanical force sensing through EGFR-ERK signaling pathways. This work has significant implications for understanding tissue integrity in development and disease contexts like cancer metastasis. Her recent publication in Science Signaling demonstrates how epithelial cells co-opt growth factor signaling for mechanotransduction, revealing novel crosstalk between adhesion complexes and signal transduction networks. Dr. Potoczky is actively involved in academic mentoring as an associate advisor for PhD research on epithelial surveillance against cell aberration, contributing to UQ's research training programs.

Michael W. Jenkinsمشاهده پروفایل

استاد

• Biomedical Engineering
• Medical Imaging
• Cardiac Imaging
• +۳ مورد دیگر

Michael W. Jenkins is a Professor of Biomedical Engineering at the Case Western Reserve University School of Medicine and a member of the Cancer Imaging Program at the Case Comprehensive Cancer Center. His research focuses on developing biomedical optics tools for studying congenital heart disease and peripheral nervous system disorders. Key techniques include optical coherence tomography (OCT), light-sheet microscopy, and infrared neuromodulation. The Jenkins Lab specializes in advancing 3D imaging modalities for real-time tissue analysis, aiming to reduce surgical delays and improve diagnostic accuracy. Research interests include rapid 3D tissue visualization to replace traditional frozen-section pathology, optical pacing of cardiac tissues, and corneal nerve imaging. His work bridges engineering and medicine, with applications in ophthalmology, cardiology, and neurology. Recent innovations include label-free microscopy techniques (e.g., MUSE imaging) and AI-driven segmentation tools for neural anatomy analysis. Publications highlight advancements in corneal crosslinking assessment, vagus nerve microanatomy characterization, and cardiac tissue imaging. The lab collaborates with industry to translate optical tools into clinical settings, emphasizing precision and real-time diagnostics. Teaching and mentorship are integral to his role, fostering interdisciplinary training in biomedical optics. Ongoing projects address unmet clinical needs in neural modulation therapies and regenerative medicine through optical platforms.

Avideh Zakhorمشاهده پروفایل

استاد

• Signal Processing
• Artificial Intelligence
• 3D Computer Vision
• +۶ مورد دیگر

Dr. Avideh Zakhor is a Professor and Qualcomm Chair at the Department of Electrical Engineering and Computer Sciences (EECS) at the University of California, Berkeley. She is affiliated with several research centers including the Berkeley Artificial Intelligence Research Lab (BAIR), Berkeley Deep Drive Initiative, Video and Image Processing Lab, and Berkeley Center for New Media (BCNM). Her career spans over three decades with significant contributions to signal processing, 3D computer vision, robotics, and deep learning. 1983 B.Sc. in Electrical Engineering from Caltech 1985 S.M. in Electrical Engineering and Computer Science from MIT 1987 Ph.D. in Electrical Engineering and Computer Science from MIT Dr. Zakhor's research interests focus on 3D computer vision, autonomous systems and robotics, deep learning, and signal/image processing. Her work spans diverse areas including drone navigation, medical imaging analysis, indoor positioning, and building energy audits. She has led projects on drone-based 3D building reconstruction, legged robot locomotion, and melanoma detection using AI. The 15 most recent publications highlight her work in several key areas: person search pre-training techniques, drone-based indoor navigation and 3D modeling, medical image segmentation for melanoma detection, hexapod robot locomotion, and proximity detection for public health. These publications demonstrate her expertise at the intersection of computer vision, robotics, and AI applications. Dr. Zakhor has received numerous prestigious awards throughout her career: 2022 Winner of Phases 1 and 2, Department of Energy E-Robot Competition 2018 Electronic Imaging Scientist of the Year by SPIE 2004 Okawa Research Grant 2002 IEEE Fellow 1992 Office of Naval Research Young Investigator Award 1990 Presidential Young Investigator (PYI) Award from President George H.W. Bush 1990 Junior Faculty Development Award 1984-1988 Hertz Fellowship 1983 Henry Ford Engineering Award 1982-1983 General Motors Scholarship Dr. Zakhor has advised numerous research projects and has been involved in significant research grants. She has founded successful companies including Indoor Reality, which develops technologies for rapid 3D mapping and visualization of buildings and assets. She leads research initiatives in various cutting-edge technologies: Unmanned Aerial Vehicles (UAV) with focus on autonomy and obstacle avoidance, perception, path planning and control Deep learning applications in legged locomotion, unsupervised learning for multimodal sensors, misinformation detection, and learning-based image compression Wi-Fi proximity detection methods for contact tracing of diseases Temporal graphical neural networks for disease prediction Detection of small objects in ultra-high resolution images 3D reconstruction and recognition

• Cell Death
• Ferroptosis
• Redox Signaling
• +۵ مورد دیگر

Professor Marcus Conrad serves as Director of the Institute of Metabolism and Cell Death at Helmholtz Munich and holds the Chair of Translational Redox Biology at the Technical University of Munich (TUM) since 2024. His research bridges basic science and translation through the identification and pharmacological targeting of key nodes in cell death and necro-inflammatory processes. Conrad earned his PhD from Helmholtz Zentrum München and Ludwig-Maximilians-University Munich with highest honors (summa cum laude), focusing on selenoproteins in transgenic mice. His academic journey includes research positions at Karolinska Institute, Yamagata University, and leadership roles at Helmholtz Zentrum München before his current directorship. Conrad's research primarily focuses on ferroptosis, a regulated cell death pathway dependent on iron and lipid peroxidation. His work explores how understanding these molecular mechanisms can prevent neurodegenerative diseases and combat cancer. He has made significant contributions to understanding the role of GPX4, FSP1, and other key regulators in ferroptosis, with implications for drug discovery and therapeutic interventions. His publication record shows a strong focus on ferroptosis mechanisms, with recent work exploring novel ferroptosis suppressors, metabolic connections to cell death pathways, and implications for diseases including cancer, neurodegeneration, and kidney disease. His research demonstrates the growing recognition of ferroptosis as a critical pathway with therapeutic potential across multiple disease areas. Galenus-von-Pergamon-Price (2024) European Cell Death Organisation (ECDO) Honorary Award 2024 Multiple ISI Highly Cited Awards (2020-2024) ERC Advanced Grant "IRONDEATH" (2020) m4 Awards for Personalized Medicine (2012, 2017) Conrad has secured significant research funding including an ERC Advanced Grant and coordinates the Deutsche Forschungsgemeinschaft Priority Programme on Ferroptosis (2021-2026) involving 25 centers. He co-founded ROSCUE THERAPEUTICS GmbH in 2020, translating his research into potential therapeutics. Conrad actively mentors researchers through his institute and has organized multiple international conferences on ferroptosis, including EMBO workshops and Cold Spring Harbor Asia conferences. His institute at Helmholtz Munich serves as a hub for ferroptosis research, bringing together experts in redox biology, cell death mechanisms, and translational medicine. Conrad's leadership has positioned his team at the forefront of understanding how regulated cell death pathways can be targeted for therapeutic benefit in multiple disease contexts.

• Translational Regulation
• RNA/Protein Quality Control
• Protein Misfolding
• +۵ مورد دیگر

Dr. Andrey L. Karamyshev is an Associate Professor in the Department of Cell Biology and Biochemistry at Texas Tech University Health Sciences Center's School of Medicine. His research focuses on molecular mechanisms of translational regulation and protein quality control, with significant contributions to understanding co-translational protein folding and targeting processes. He leads an active laboratory investigating fundamental cellular pathways with direct implications for human diseases. His primary research interests center on translational regulation mechanisms , particularly the RAPP (Regulation of Aberrant Protein Production) pathway discovered by his team, which monitors nascent chain interactions during translation to prevent defective protein synthesis. His work explores protein misfolding in neurodegenerative diseases like Alzheimer's and Parkinson's, investigating how loss of co-translational interactions leads to pathological aggregation. Additional research areas include ribosome specialization, mRNA quality control, and translational adaptations in parasitic organisms like Leishmania. Analysis of his recent publications (2020-2023) reveals consistent focus on protein quality control pathways , with particular emphasis on the Signal Recognition Particle (SRP) system and its intersections with neurodegenerative disease mechanisms. His work increasingly bridges fundamental molecular biology with therapeutic applications, especially in parasitic diseases and neurodegeneration. Faculty of 1000 recommendation (2014) Faculty of 1000 recommendation (2005) Faculty of 1000 recommendation (2003) Editors' Highlights in Microbiology and Infectious Diseases (Nature Communications, 2023) Dr. Karamyshev actively recruits graduate students to his laboratory, where researchers employ advanced techniques including site-specific photo-crosslinking, iPINCH (identification of Proteins Interacting with Nascent Chains), unnatural amino acid incorporation, and ribosome profiling. His lab has secured research funding supporting investigations into translational regulation mechanisms with potential pharmaceutical applications for neurodegenerative and parasitic diseases. Current projects include elucidating the complete RAPP pathway mechanism and exploring co-translational protein interactions in neurodegenerative disease models. His laboratory maintains active collaborations across Texas Tech University and Texas Tech University Health Sciences Center, particularly with parasitology and neuroscience research groups. The team utilizes specialized methodologies for studying nascent chain interactions both in vitro and in human cell culture systems, with growing focus on translational applications for disease treatment.